United States 20s Proteasome Market Report 2018

March 2018 | 104 pages | ID: UEF86EDA555QEN
QYResearch

Abstracts

In this report, the United States 20s Proteasome market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of 20s Proteasome in these regions, from 2013 to 2025 (forecast).

United States 20s Proteasome market competition by top manufacturers/players, with 20s Proteasome sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Amgen Inc
• Celgene Corp

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Marizomib
• Oprozomib
• Carfilzomib
• VPEA-002
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Colon Cancer
• Lymphoma
• Malignant Glioma
• Neuroendocrine Cancer
• Ovarian Cancer
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States 20s Proteasome Market Report 2018

1 20S PROTEASOME OVERVIEW

1.1 Product Overview and Scope of 20s Proteasome
1.2 Classification of 20s Proteasome by Product Category
  1.2.1 United States 20s Proteasome Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States 20s Proteasome Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Marizomib
  1.2.4 Oprozomib
  1.2.5 Carfilzomib
  1.2.6 VPEA-002
  1.2.7 Others
1.3 United States 20s Proteasome Market by Application/End Users
  1.3.1 United States 20s Proteasome Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Colon Cancer
  1.3.3 Lymphoma
  1.3.4 Malignant Glioma
  1.3.5 Neuroendocrine Cancer
  1.3.6 Ovarian Cancer
  1.3.7 Others
1.4 United States 20s Proteasome Market by Region
  1.4.1 United States 20s Proteasome Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West 20s Proteasome Status and Prospect (2013-2025)
  1.4.3 Southwest 20s Proteasome Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic 20s Proteasome Status and Prospect (2013-2025)
  1.4.5 New England 20s Proteasome Status and Prospect (2013-2025)
  1.4.6 The South 20s Proteasome Status and Prospect (2013-2025)
  1.4.7 The Midwest 20s Proteasome Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of 20s Proteasome (2013-2025)
  1.5.1 United States 20s Proteasome Sales and Growth Rate (2013-2025)
  1.5.2 United States 20s Proteasome Revenue and Growth Rate (2013-2025)

2 UNITED STATES 20S PROTEASOME MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States 20s Proteasome Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States 20s Proteasome Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States 20s Proteasome Average Price by Players/Suppliers (2013-2018)
2.4 United States 20s Proteasome Market Competitive Situation and Trends
  2.4.1 United States 20s Proteasome Market Concentration Rate
  2.4.2 United States 20s Proteasome Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers 20s Proteasome Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES 20S PROTEASOME SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States 20s Proteasome Sales and Market Share by Region (2013-2018)
3.2 United States 20s Proteasome Revenue and Market Share by Region (2013-2018)
3.3 United States 20s Proteasome Price by Region (2013-2018)

4 UNITED STATES 20S PROTEASOME SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States 20s Proteasome Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States 20s Proteasome Revenue and Market Share by Type (2013-2018)
4.3 United States 20s Proteasome Price by Type (2013-2018)
4.4 United States 20s Proteasome Sales Growth Rate by Type (2013-2018)

5 UNITED STATES 20S PROTEASOME SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States 20s Proteasome Sales and Market Share by Application (2013-2018)
5.2 United States 20s Proteasome Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES 20S PROTEASOME PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Amgen Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 20s Proteasome Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Amgen Inc 20s Proteasome Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Celgene Corp
  6.2.2 20s Proteasome Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Celgene Corp 20s Proteasome Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview

7 20S PROTEASOME MANUFACTURING COST ANALYSIS

7.1 20s Proteasome Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of 20s Proteasome

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 20s Proteasome Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of 20s Proteasome Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES 20S PROTEASOME MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States 20s Proteasome Sales Volume, Revenue Forecast (2018-2025)
11.2 United States 20s Proteasome Sales Volume Forecast by Type (2018-2025)
11.3 United States 20s Proteasome Sales Volume Forecast by Application (2018-2025)
11.4 United States 20s Proteasome Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of 20s Proteasome
Figure United States 20s Proteasome Market Size (K Pcs) by Type (2013-2025)
Figure United States 20s Proteasome Sales Volume Market Share by Type (Product Category) in 2017
Figure Marizomib Product Picture
Figure Oprozomib Product Picture
Figure Carfilzomib Product Picture
Figure VPEA-002 Product Picture
Figure Others Product Picture
Figure United States 20s Proteasome Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of 20s Proteasome by Application in 2017
Figure Colon Cancer Examples
Table Key Downstream Customer in Colon Cancer
Figure Lymphoma Examples
Table Key Downstream Customer in Lymphoma
Figure Malignant Glioma Examples
Table Key Downstream Customer in Malignant Glioma
Figure Neuroendocrine Cancer Examples
Table Key Downstream Customer in Neuroendocrine Cancer
Figure Ovarian Cancer Examples
Table Key Downstream Customer in Ovarian Cancer
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States 20s Proteasome Market Size (Million USD) by Region (2013-2025)
Figure The West 20s Proteasome Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest 20s Proteasome Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic 20s Proteasome Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England 20s Proteasome Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US 20s Proteasome Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest 20s Proteasome Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States 20s Proteasome Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States 20s Proteasome Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States 20s Proteasome Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States 20s Proteasome Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States 20s Proteasome Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States 20s Proteasome Sales Share by Players/Suppliers
Figure 2017 United States 20s Proteasome Sales Share by Players/Suppliers
Figure United States 20s Proteasome Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States 20s Proteasome Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States 20s Proteasome Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States 20s Proteasome Revenue Share by Players/Suppliers
Figure 2017 United States 20s Proteasome Revenue Share by Players/Suppliers
Table United States Market 20s Proteasome Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market 20s Proteasome Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States 20s Proteasome Market Share of Top 3 Players/Suppliers
Figure United States 20s Proteasome Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers 20s Proteasome Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers 20s Proteasome Product Category
Table United States 20s Proteasome Sales (K Pcs) by Region (2013-2018)
Table United States 20s Proteasome Sales Share by Region (2013-2018)
Figure United States 20s Proteasome Sales Share by Region (2013-2018)
Figure United States 20s Proteasome Sales Market Share by Region in 2017
Table United States 20s Proteasome Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States 20s Proteasome Revenue Share by Region (2013-2018)
Figure United States 20s Proteasome Revenue Market Share by Region (2013-2018)
Figure United States 20s Proteasome Revenue Market Share by Region in 2017
Table United States 20s Proteasome Price (USD/Pcs) by Region (2013-2018)
Table United States 20s Proteasome Sales (K Pcs) by Type (2013-2018)
Table United States 20s Proteasome Sales Share by Type (2013-2018)
Figure United States 20s Proteasome Sales Share by Type (2013-2018)
Figure United States 20s Proteasome Sales Market Share by Type in 2017
Table United States 20s Proteasome Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States 20s Proteasome Revenue Share by Type (2013-2018)
Figure Revenue Market Share of 20s Proteasome by Type (2013-2018)
Figure Revenue Market Share of 20s Proteasome by Type in 2017
Table United States 20s Proteasome Price (USD/Pcs) by Types (2013-2018)
Figure United States 20s Proteasome Sales Growth Rate by Type (2013-2018)
Table United States 20s Proteasome Sales (K Pcs) by Application (2013-2018)
Table United States 20s Proteasome Sales Market Share by Application (2013-2018)
Figure United States 20s Proteasome Sales Market Share by Application (2013-2018)
Figure United States 20s Proteasome Sales Market Share by Application in 2017
Table United States 20s Proteasome Sales Growth Rate by Application (2013-2018)
Figure United States 20s Proteasome Sales Growth Rate by Application (2013-2018)
Table Amgen Inc Basic Information List
Table Amgen Inc 20s Proteasome Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Amgen Inc 20s Proteasome Sales Growth Rate (2013-2018)
Figure Amgen Inc 20s Proteasome Sales Market Share in United States (2013-2018)
Figure Amgen Inc 20s Proteasome Revenue Market Share in United States (2013-2018)
Table Celgene Corp Basic Information List
Table Celgene Corp 20s Proteasome Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Celgene Corp 20s Proteasome Sales Growth Rate (2013-2018)
Figure Celgene Corp 20s Proteasome Sales Market Share in United States (2013-2018)
Figure Celgene Corp 20s Proteasome Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of 20s Proteasome
Figure Manufacturing Process Analysis of 20s Proteasome
Figure 20s Proteasome Industrial Chain Analysis
Table Raw Materials Sources of 20s Proteasome Major Players/Suppliers in 2017
Table Major Buyers of 20s Proteasome
Table Distributors/Traders List
Figure United States 20s Proteasome Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States 20s Proteasome Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States 20s Proteasome Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States 20s Proteasome Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States 20s Proteasome Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States 20s Proteasome Sales Volume (K Pcs) Forecast by Type in 2025
Table United States 20s Proteasome Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States 20s Proteasome Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States 20s Proteasome Sales Volume (K Pcs) Forecast by Application in 2025
Table United States 20s Proteasome Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States 20s Proteasome Sales Volume Share Forecast by Region (2018-2025)
Figure United States 20s Proteasome Sales Volume Share Forecast by Region (2018-2025)
Figure United States 20s Proteasome Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources